| 0 (0%) | 04-23 10:09 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.33 | 1-year : | 0.38 |
| Resists | First : | 0.28 | Second : | 0.33 |
| Pivot price | 0.23  |
|||
| Supports | First : | 0.2 | Second : | 0.17 |
| MAs | MA(5) : | 0.22 |
MA(20) : | 0.25 |
| MA(100) : | 0.37 |
MA(250) : | 0.49 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 24.4 |
D(3) : | 18.3 |
| RSI | RSI(14): 40.8 |
|||
| 52-week | High : | 1.08 | Low : | 0.2 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ EGLX ] has closed above bottom band by 33.7%. Bollinger Bands are 58.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.23 - 0.24 | 0.24 - 0.24 |
| Low: | 0.22 - 0.22 | 0.22 - 0.22 |
| Close: | 0.23 - 0.23 | 0.23 - 0.23 |
Mon, 06 Jul 2020
Endologix files for bankruptcy, will go private - Mass Device
Sat, 22 Feb 2020
Endologix, Inc. Just Reported, And Analysts Assigned A US$3.80 Price Target - Yahoo Finance
Thu, 20 Jun 2019
Endologix, Inc. (ELGX) Shares March Higher, Can It Continue? - Yahoo Movies UK
Tue, 27 Oct 2015
Endologix, TriVascular Technologies ink $211m merger - Mass Device
Wed, 25 Mar 2015
Lombard's Unique Stent-Graft Rapidly Penetrating Endovascular Aneurysm Repair Market (NASDAQ:EVAR-DEFUNCT ... - Seeking Alpha
Mon, 24 Mar 2014
Leading Equity Analyst Sees M&A and IPOs a Theme for Medical Device Sector in 2014 - Yahoo Singapore News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 155 (M) |
| Shares Float | 138 (M) |
| Held by Insiders | 14.6 (%) |
| Held by Institutions | 6.8 (%) |
| Shares Short | 1,090 (K) |
| Shares Short P.Month | 1,030 (K) |
| EPS | -0.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.53 |
| Profit Margin | -35.8 % |
| Operating Margin | -22.5 % |
| Return on Assets (ttm) | -7.2 % |
| Return on Equity (ttm) | -25.7 % |
| Qtrly Rev. Growth | -16.8 % |
| Gross Profit (p.s.) | 0.41 |
| Sales Per Share | 1.22 |
| EBITDA (p.s.) | -0.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -23 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.69 |
| PEG Ratio | 0 |
| Price to Book value | 0.14 |
| Price to Sales | 0.18 |
| Price to Cash Flow | -1.57 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|